T C Flynn

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Botox in men
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, NC 27512, USA
    Dermatol Ther 20:407-13. 2007
  2. doi Advances in the use of botulinum neurotoxins in facial esthetics
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Cosmet Dermatol 11:42-50. 2012
  3. doi Validated assessment scales for the upper face
    Timothy C Flynn
    Department of Dermatology, University of North Carolina at Chapel Hill, NC, USA
    Dermatol Surg 38:309-19. 2012
  4. ncbi Update on botulinum toxin
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA
    Semin Cutan Med Surg 25:115-21. 2006
  5. ncbi Denial of illness: Basal cell carcinoma
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina, USA
    Dermatol Surg 30:1343-4. 2004
  6. ncbi Myobloc
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27514, USA
    Dermatol Clin 22:207-11, vii. 2004
  7. ncbi Periocular botulinum toxin
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    Clin Dermatol 21:498-504. 2003
  8. doi Use of intraoperative botulinum toxin in facial reconstruction
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, NC 27519, USA
    Dermatol Surg 35:182-8. 2009
  9. ncbi Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Dermatol Surg 29:943-50; discussion 950-1. 2003
  10. ncbi Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, North Carolina 27519, USA
    Dermatol Surg 29:519-22; discussion 522. 2003

Collaborators

Detail Information

Publications25

  1. ncbi Botox in men
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, NC 27512, USA
    Dermatol Ther 20:407-13. 2007
    ..BTX-A can be used to reduce axillary sweating and improve armpit odor. BTX-A shows promise in treating benign prostatic hyperplasia, and may in the future become a first-line treatment...
  2. doi Advances in the use of botulinum neurotoxins in facial esthetics
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Cosmet Dermatol 11:42-50. 2012
    ..To present the latest findings and future developments in the cosmetic use of botulinum neurotoxin...
  3. doi Validated assessment scales for the upper face
    Timothy C Flynn
    Department of Dermatology, University of North Carolina at Chapel Hill, NC, USA
    Dermatol Surg 38:309-19. 2012
    ..The development of globally accepted tools to assess these changes objectively is an essential contribution to aesthetic research and routine clinical medicine...
  4. ncbi Update on botulinum toxin
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA
    Semin Cutan Med Surg 25:115-21. 2006
    ..Other forms of botulinum toxins (additional type A or type B toxins) are available, each with advantages and disadvantages...
  5. ncbi Denial of illness: Basal cell carcinoma
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina, USA
    Dermatol Surg 30:1343-4. 2004
  6. ncbi Myobloc
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27514, USA
    Dermatol Clin 22:207-11, vii. 2004
    ..This article explains the difference between Myobloc and type A toxins, reviews equivalency and other published studies, and describes practical uses for this product in facial aesthetics...
  7. ncbi Periocular botulinum toxin
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    Clin Dermatol 21:498-504. 2003
    ..BOTOX holds U.S. Food and Drug Administration approval in the United States for treatment of glabellar lines. BOTOX is in widespread use worldwide and is currently the most popular cosmetic treatment in the United States...
  8. doi Use of intraoperative botulinum toxin in facial reconstruction
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, NC 27519, USA
    Dermatol Surg 35:182-8. 2009
    ..Botulinum toxin is a potent neuromodulator that temporarily relaxes muscles and can improve wound healing...
  9. ncbi Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Dermatol Surg 29:943-50; discussion 950-1. 2003
    ..Periocular wrinkles such as lateral orbital rhytids respond well to treatment. BOTOX can be used in the lower eyelid to improve wrinkles and widen the eye...
  10. ncbi Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, North Carolina 27519, USA
    Dermatol Surg 29:519-22; discussion 522. 2003
    ..Botulinum toxin types A and B can improve the appearance of facial wrinkles. Differences in the time until onset and the degree of diffusion have been observed anecdotally, but no direct comparative studies have been done...
  11. doi Botulinum toxin: examining duration of effect in facial aesthetic applications
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, North Carolina, USA
    Am J Clin Dermatol 11:183-99. 2010
    ..Additional research should help clarify the impact of age, baseline rhytid severity, patient sex, repeated treatments, and combination treatment on longevity of effect...
  12. ncbi Powered liposuction: an evaluation of currently available instrumentation
    Timothy Corcoran Flynn
    Department of Dermatology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
    Dermatol Surg 28:376-82. 2002
    ..This motion simulates the standard human movement of the cannula and facilitates movement through the tissue. Powered liposuction may help to prevent surgeon fatigue and has recently been shown to aid in the efficacy of fat removal...
  13. doi Comparative histology of intradermal implantation of mono and biphasic hyaluronic acid fillers
    Timothy Corcoran Flynn
    Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina, USA
    Dermatol Surg 37:637-43. 2011
    ..Different technologies are employed in cross-linking, and the products have varying rheological properties...
  14. ncbi Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye
    T C Flynn
    Department of Dermatology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
    Dermatol Surg 27:703-8. 2001
    ..Two units of BTX-A injected into the lower eyelid orbicularis oculi muscle improves infraorbital wrinkles, particularly when used in combination with BTX-A treatment of the lateral orbital area...
  15. ncbi Does transferred fat retain properties of its site of origin?
    Timothy Corcoran Flynn
    Cary Skin Center, and University of North Carolina Chapel Hill, Cary, NC, USA
    Dermatol Surg 32:405-6. 2006
  16. ncbi Unilateral transient forehead paralysis following injury to the temporal branch of the facial nerve
    T C Flynn
    Department of Dermatology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA
    Int J Dermatol 38:474-7. 1999
    ..Cutaneous surgery in the temporal region of the forehead can lead to injury to the superficial temporal branch of the facial nerve. A flattened forehead and with ipsilateral forehead paralysis can occur with damage to this nerve...
  17. ncbi The efficacy of powered liposuction
    W P Coleman
    Department of Dermatology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
    Dermatol Surg 27:735-8. 2001
    ..the overall increased extraction in powered vs. nonpowered mode was 30%. CONCLUSION: The powered liposuction devices tested significantly increase the efficacy of subcutaneous fat removal during liposuction...
  18. ncbi Topical revitalization of body skin
    T C Flynn
    Department of Dermatology, Tulane University School of Medicine, New Orleans, LA 70112 2699, USA
    J Eur Acad Dermatol Venereol 14:280-4. 2000
    ..Chemical peeling for the body can improve the skin with the use of alpha- or beta-hydroxy acids. While topical therapy can improve body skin, adjunctive surgical therapy may be needed to correct body skin disorders or concerns fully...
  19. ncbi Treatment of nasal wrinkles with botulinum toxin
    Bhertha M Tamura
    Dermatology Department, Santo Amaro University, Sao Paulo, Brazil
    Dermatol Surg 31:271-5. 2005
    ..Between 2 and 5 U of botulinum toxin have commonly been used. However, clinicians have observed that some nasal wrinkles persist following nasalis treatment...
  20. ncbi A practical guide to achieving successful outcomes with botulinum toxin type A. IMCAS Meeting, Paris 2002
    Benjamin Ascher
    J Cosmet Laser Ther 4:1-6. 2002
  21. ncbi Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines
    Alastair Carruthers
    University of British Columbia, Vancouver, British Columbia, Canada
    Dermatol Surg 33:S60-8. 2007
    ..Previous open-label studies have demonstrated that botulinum toxin type B (BTX-B, Myobloc, Solstice Neurosciences) in doses of up to 3,000 U is safe and effective in the treatment of glabellar wrinkles...
  22. ncbi Update on botulinum toxin
    Timothy Corcoran Flynn
    Cary Skin Center, Cary, NC, USA
    Semin Cutan Med Surg 26:196-202. 2007
    ..Other forms of botulinum toxins (additional type A or type B toxins) are available, each with advantages and disadvantages...
  23. ncbi Surgical pearl: the use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections
    Timothy Corcoran Flynn
    Department of Dermatology, Tulane University Medical School, New Orleans, Louisiana 70112, USA
    J Am Acad Dermatol 46:931-3. 2002
  24. ncbi Liposuction using dilute local anesthesia
    Timothy Corcoran Flynn
    Dermatol Surg 29:1144-5. 2003
  25. ncbi Lexicon of areas amenable to liposuction
    Kyle Coleman
    Ochsner Clinic, New Orleans, Louisiana, USA
    Dermatol Surg 32:558-61. 2006
    ..Areas amenable to liposuction are identified by a variety of terms. Both common and professional language is used...